Californias Tarsus Pharmaceuticals (Nasdaq: TARS) has announced positive top-line results from the Phase IIa CARPO trial.
The Irvine-based company is running the trial to test the efficacy of TP-05, also known as lotilaner, in the prevention of Lyme disease.
The most common vector-borne disease in the USA, Lyme disease is transmitted to humans following the bite of ticks which carry it.
If caught early, a short course of oral antibiotics, such
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user pleaselogin. If your trial has come to an end, you cansubscribe here.
Try before you buy
All the news that moves the needle in pharma and biotech. Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. Daily roundup of key events in pharma and biotech. Monthly in-depth briefings on Boardroom appointments and M&A news. Choose from a cost-effective annual package or a flexible monthly subscription.
See more here:
New way to combat Lyme disease performs will in mid-stage trial - The Pharma Letter
- Bella Hadid Says She's 'Almost 10 Months' Sober In Inspiring Post - The Blast - August 3rd, 2023 [August 3rd, 2023]
- 'Crisis intervention' where police once went - POLITICO - POLITICO - August 3rd, 2023 [August 3rd, 2023]
- Using herbs to treat Lyme disease, Bartonella, and Babesia - LymeDisease.org - August 3rd, 2023 [August 3rd, 2023]
- Lyme disease cases on near-record pace in Maine as tick population thrives - Press Herald - August 3rd, 2023 [August 3rd, 2023]
- How is Justin Bieber's Health? The chart-topping Pop-star's struggles with Lyme and Facial Paralysis - Sportskeeda - January 19th, 2024 [January 19th, 2024]
- Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key ... - PR Newswire - January 19th, 2024 [January 19th, 2024]
- Support group question: Does anyone ever get better? - LymeDisease.org - January 19th, 2024 [January 19th, 2024]
- Embers' newest CME course on Lyme treatment--and more - LymeDisease.org - January 19th, 2024 [January 19th, 2024]
- Lyme disease cases spike Down East and set record for Maine - Press Herald - January 19th, 2024 [January 19th, 2024]
- Who Is Daisy Kent? All About Joey's Contestant On 'The Bachelor' Season 28Life, Job, Hearing Loss, More - Women's Health - February 28th, 2024 [February 28th, 2024]
- Health official: Tick season to begin early in Michigan due to mild winter - WZZM13.com - February 28th, 2024 [February 28th, 2024]
- Ask the doctors: Antibiotics can temporarily wipe out the gut microbiome - The Spokesman Review - February 28th, 2024 [February 28th, 2024]
- Proposed bill calls for greater monitoring of alpha-gal syndrome - LymeDisease.org - February 28th, 2024 [February 28th, 2024]
- Tracking Ticks In Georgia To Help Monitor Emerging Diseases - Eurasia Review - April 12th, 2024 [April 12th, 2024]
- Be Vigilant in Preventing Tick-borne Illness this Spring - Health.mil - April 12th, 2024 [April 12th, 2024]
- Tick Infects Woman with 5 Diseases - PEOPLE - April 12th, 2024 [April 12th, 2024]
- Six teams advance to Phase 3 of LymeX Diagnostics Prize - LymeDisease.org - April 12th, 2024 [April 12th, 2024]
- Trista Sutter Gives Update on Husband Ryan's Lyme Disease - PEOPLE - April 12th, 2024 [April 12th, 2024]
- Bachelor Nation's Trista Sutter Shares Update on Husband Ryan Sutter's Battle With Lyme Disease - E! Online - E! NEWS - April 12th, 2024 [April 12th, 2024]